Canton Strategic Holdings (CNTN) Total Debt (2020 - 2025)

Canton Strategic Holdings (CNTN) posted Total Debt of $161117.0 for Q3 2025, down 35.48% on a QoQ basis from $249716.0 in Q2 2025.

Canton Strategic Holdings (CNTN) Total Debt (2020 - 2025) Analysis & Trends

Canton Strategic Holdings' Total Debt history runs 4 years deep, the most recent figure standing at $161117.0 for Q3 2025.

Quarterly Total Debt changed N/A year-over-year to $161117.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $161117.0 (changed N/A YoY) and the FY2021 annual result came in at $200000.0, down 50.22% from the prior year.
Total Debt was $161117.0 for Q3 2025 at Canton Strategic Holdings, down from $249716.0 in the prior quarter.
Across five years, Total Debt topped out at $271454.0 in Q1 2025 and bottomed at $161117.0 in Q3 2025.
A 3-year average of $216457.4 and a median of $200000.0 in 2021 frame the typical range for Total Debt.
Peak annual rise in Total Debt reached 50.22% in 2021, while the deepest fall reached 50.22% in 2021.
Canton Strategic Holdings' Total Debt stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then decreased by 19.44% to $161117.0 in 2025.
Business Quant data shows CNTN's Total Debt at $161117.0 in Q3 2025, $249716.0 in Q2 2025, and $271454.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	110.96 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	959.06 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	1.99 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Canton Strategic Holdings	427.87 Mn	427.87 Mn	-	-

Download Data